2-[4-(Pyridin-4-yl)-1,3-thiazol-2-yl]acetonitrile hydrobromide

Catalog No. :
ACBPOC424
CAS No. :
1197837-00-5
Molecular Formula :
C10H8BrN3S
Molecular Weight :
282.17

IUPAC Name:2-(4-(pyridin-4-yl)thiazol-2-yl)acetonitrile hydrobromide

2-[4-(Pyridin-4-yl)-1,3-thiazol-2-yl]acetonitrile hydrobromide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$63.00Login to see priceInquiryInquiry
250mg95%$80.00Login to see priceInquiryInquiry
1g95%$183.00Login to see priceInquiryInquiry
5g95%$514.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-[4-(Pyridin-4-yl)-1,3-thiazol-2-yl]acetonitrile hydrobromide
IUPAC Name2-(4-(pyridin-4-yl)thiazol-2-yl)acetonitrile hydrobromide
MDL No.MFCD13195898
Molecular FormulaC10H8BrN3S
Molecular Weight282.17
SMILESN#CCC1=NC(C2=CC=NC=C2)=CS1.[H]Br
InChI KeyVSHKSFZUNWBHKP-UHFFFAOYSA-N
Synonym2-[4-(pyridin-4-yl)-1,3-thiazol-2-yl]acetonitrile hydrobromide
CAS No.1197837-00-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACBPOC424 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPUEM923 route compound structure diagram
    ACPUEM9237357-70-2 In Stock
  2. Plus
  3. ACATZO089 route compound structure diagram
    ACATZO0895349-17-7 In Stock
  4. Then
  5. ACBPOC424 route product structure diagram
    ACBPOC4241197837-00-5
Inquiry

2. ACBPOC424 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPUEM923 route compound structure diagram
    ACPUEM9237357-70-2 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBPOC424 route product structure diagram
    ACBPOC4241197837-00-5
Inquiry

Comments (0)